Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00196_DB00549_nanopub.RAbYLLzxkzc5IWMCHPH8hpdxAIOdow27K_zSug2cDysQ0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00196_DB00549 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00196_DB00549 label "DDI between Fluconazole and Zafirlukast - Fluconazole, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of zafirlukast. Consider alternate therapy or monitor for changes in zafirlukast therapeutic and adverse effects if fluconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00196_DB00549]" assertion.
- drugbank_resource:DB00196_DB00549 identifier "drugbank_resource:DB00196_DB00549" assertion.
- drugbank_resource:DB00196_DB00549 title "DDI between Fluconazole and Zafirlukast - Fluconazole, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of zafirlukast. Consider alternate therapy or monitor for changes in zafirlukast therapeutic and adverse effects if fluconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00196 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB00549 assertion.
- drugbank:DB00549 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB00549 assertion.